1. Home
  2. AMPH vs CET Comparison

AMPH vs CET Comparison

Compare AMPH & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • CET
  • Stock Information
  • Founded
  • AMPH 1996
  • CET 1929
  • Country
  • AMPH United States
  • CET United States
  • Employees
  • AMPH N/A
  • CET N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • CET Finance/Investors Services
  • Sector
  • AMPH Health Care
  • CET Finance
  • Exchange
  • AMPH Nasdaq
  • CET Nasdaq
  • Market Cap
  • AMPH 1.1B
  • CET 1.2B
  • IPO Year
  • AMPH 2014
  • CET N/A
  • Fundamental
  • Price
  • AMPH $25.52
  • CET $47.14
  • Analyst Decision
  • AMPH Hold
  • CET
  • Analyst Count
  • AMPH 5
  • CET 0
  • Target Price
  • AMPH $38.00
  • CET N/A
  • AVG Volume (30 Days)
  • AMPH 521.8K
  • CET 19.6K
  • Earning Date
  • AMPH 05-07-2025
  • CET 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • CET 4.79%
  • EPS Growth
  • AMPH N/A
  • CET 26.33
  • EPS
  • AMPH 2.77
  • CET 9.95
  • Revenue
  • AMPH $730,659,000.00
  • CET $23,698,535.00
  • Revenue This Year
  • AMPH $0.65
  • CET N/A
  • Revenue Next Year
  • AMPH $5.26
  • CET N/A
  • P/E Ratio
  • AMPH $9.23
  • CET $4.69
  • Revenue Growth
  • AMPH 8.05
  • CET 11.75
  • 52 Week Low
  • AMPH $22.64
  • CET $40.24
  • 52 Week High
  • AMPH $53.96
  • CET $49.51
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 53.84
  • CET 65.99
  • Support Level
  • AMPH $25.13
  • CET $45.89
  • Resistance Level
  • AMPH $26.57
  • CET $46.90
  • Average True Range (ATR)
  • AMPH 0.71
  • CET 0.52
  • MACD
  • AMPH 0.17
  • CET -0.03
  • Stochastic Oscillator
  • AMPH 62.90
  • CET 95.36

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

Share on Social Networks: